TriSalus Life Sciences Files 2025 Proxy Statement
Ticker: TLSIW · Form: DEF 14A · Filed: Apr 30, 2025 · CIK: 1826667
| Field | Detail |
|---|---|
| Company | Trisalus Life Sciences, Inc. (TLSIW) |
| Form Type | DEF 14A |
| Filed Date | Apr 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, governance, annual-meeting
TL;DR
TriSalus Life Sciences DEF 14A is out. Vote your shares!
AI Summary
TriSalus Life Sciences, Inc. filed its definitive proxy statement on April 30, 2025, for the fiscal year ending December 31, 2024. The company, formerly known as MedTech Acquisition Corp until September 30, 2020, is seeking shareholder approval for matters related to its annual meeting. The filing details executive compensation, board nominations, and other corporate governance issues relevant to its shareholders.
Why It Matters
This filing provides shareholders with crucial information regarding company leadership, executive compensation, and voting matters, enabling informed participation in corporate governance decisions.
Risk Assessment
Risk Level: low — This is a routine annual proxy filing and does not contain new material financial or operational information that would inherently increase risk.
Key Numbers
- 2024 — Fiscal Year End (The proxy statement covers the company's performance and governance for the fiscal year ending December 31, 2024.)
Key Players & Entities
- TriSalus Life Sciences, Inc. (company) — Registrant
- MedTech Acquisition Corp (company) — Former company name
- 20250430 (date) — Filing date
- 20250612 (date) — Period of report
- 0001826667-25-000040 (filing_id) — Accession Number
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose is to provide shareholders with information and solicit their votes for the annual meeting, covering matters such as director elections and executive compensation.
When was TriSalus Life Sciences, Inc. formerly known as?
TriSalus Life Sciences, Inc. was formerly known as MedTech Acquisition Corp until September 30, 2020.
What is the filing date of this proxy statement?
This definitive proxy statement was filed on April 30, 2025.
What is the fiscal year end for TriSalus Life Sciences, Inc.?
The company's fiscal year ends on December 31.
What is the SIC code for TriSalus Life Sciences, Inc.?
The Standard Industrial Classification (SIC) code for TriSalus Life Sciences, Inc. is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 30, 2025 regarding TriSalus Life Sciences, Inc. (TLSIW).